Curcumin is known to inhibit TGF-β signaling in breast and pancreatic cancers [29, 30] while emodin is known to differentially regulate TGF-β signaling in a context dependent manner [31, 32], however, the effect of these phytochemicals on TGF-β signaling in cervical cancer cells remains to be studied. Here, TGFB1 is linked to pancreatic neoplasm.